Mon, November 9, 2026
|
CannabisInsightKorea's Cannabis Business & Policy Media

Korean Cannabis Legislation

Tracking cannabis, hemp, and CBD-related bills in the Korean National Assembly — proposal status and committee review progress.

Bill No. 2221952Committee Review

Special Bill on the Promotion and Support of the Hemp Industry

Rep. 박지원 et al. (10 lawmakers in total) · Proposed 2026-10-19 · Agriculture, Food, Rural Affairs, Oceans and Fisheries Committee

View Bill →
Received
Committee Review
Legal Review
Plenary Session
Sent to Gov.
Enacted

Referred to the competent committee on 22 October 2026. No agenda date, decision date or decision result was listed when checked. Public consultation period: 26 October–9 November 2026. Checked: .

The bill would define hemp as Cannabis-genus plants or their parts containing no more than 0.3% delta-9 THC by dry weight. It combines MAFRA-led industry development and cultivation licensing with MFDS product licensing, safety review and ingredient standards. Introduced by 박지원 and nine other lawmakers, it remains pending at committee stage. It does not establish enacted cultivation or sales permissions.

Key Provisions

  • ✓Defines hemp using a dry-weight delta-9 THC threshold of 0.3%, not a total-THC threshold
  • ✓Provides five-year and annual MAFRA plans, industry and safety institutions, and a traceability information system
  • ✓Requires MAFRA cultivation and breeding licences in designated safety areas, composition testing before shipment, and production and disposal reporting
  • ✓Requires MFDS licensing and product-level safety and quality review, with export declarations and ingredient standards
  • ✓Keeps medicines, foods and cosmetics subject to their respective laws; it is not blanket permission to sell finished products
#Hemp#Hemp Special Bill#Delta-9 THC 0.3%#Industry Promotion#Safety Regulation#Traceability
View related news summary →
Bill No. 2217773Committee Review

Partial Amendment to the Act on the Control of Narcotics

Rep. 서미화 et al. (10 lawmakers in total) · Proposed 2026-03-26 · Health and Welfare Committee

View Bill →
Received
Committee Review
Legal Review
Plenary Session
Sent to Gov.
Enacted

This bill would classify cannabis-derived components with medical utility, including CBD, as psychotropic medicines, enabling domestic manufacture and marketing authorization. It would also create a licensing framework for cannabis cultivation for medical purposes, clarify the statutory definition of cannabis in line with Supreme Court case 2022du60776, and establish a designated raw-material management support center for medical narcotics.

Key Provisions

  • ✓Classifies CBD and other cannabis-derived components as psychotropic medicines, allowing domestic drug manufacture and marketing authorization
  • ✓Expands the definition of medical-purpose cannabis cultivators and creates an MFDS licensing procedure
  • ✓Creates a designated raw-material management support center for medical narcotics
  • ✓Clarifies that CBD falls within the legal definition of cannabis, reflecting Supreme Court precedent
#CBD#Medical Cannabis#Act on the Control of Narcotics#Domestic Manufacturing
Bill No. 2217027Committee Review

Special Act on Fostering the Hemp Industry and Ensuring Hemp Safety

Rep. 윤준병 et al. (11 lawmakers in total) · Proposed 2026-02-25 · Agriculture, Food, Rural Affairs, Oceans and Fisheries Committee

View Bill →
Received
Committee Review
Legal Review
Plenary Session
Sent to Gov.
Enacted

A dedicated hemp statute that would define cannabis below a specified THC threshold as hemp and establish a safety-management framework for cultivation, processing, distribution and sale. It would create a legal basis for hemp applications in medical, food and industrial sectors, while building industry infrastructure through a Hemp Industry Promotion Institute and designated hemp clusters.

Key Provisions

  • ✓Defines hemp separately from narcotics for cannabis below the statutory THC threshold
  • ✓Introduces licensing for hemp cultivation, breeding, manufacturing and sales, involving both agriculture and food-safety authorities
  • ✓Establishes a Hemp Industry Promotion Institute and a five-year comprehensive plan
  • ✓Creates a designation system for regional hemp industry clusters
  • ✓Builds a hemp traceability-management system led by the Ministry of Food and Drug Safety
#Hemp#Hemp Special Act#Industry Promotion#Cultivation License#Hemp Industry Promotion Institute
Bill No. 2219769Committee Review

Partial Amendment to the Act on the Control of Narcotics

Rep. 김형동 et al. (13 lawmakers in total) · Proposed 2026-07-06 · Health and Welfare Committee

View Bill →
Received
Committee Review
Legal Review
Plenary Session
Sent to Gov.
Enacted

This bill would classify medically useful cannabis-derived components, including CBD, as psychotropic medicines and permit domestic manufacture. It would create a licensing framework for medical cannabis cultivators and establish a state-led raw-material management center for medical narcotics, overseeing the supply chain from cultivation through extraction, manufacturing and allocation.

Key Provisions

  • ✓Classifies CBD and other cannabis-derived components as psychotropic medicines, allowing domestic drug manufacture and marketing authorization
  • ✓Creates an MFDS licensing framework for medical-purpose cannabis cultivation
  • ✓Establishes a state-led raw-material management center for medical narcotics
  • ✓Sets up state oversight from cultivation and extraction through manufacturing and raw-material allocation
#CBD#Medical Cannabis#Act on the Control of Narcotics#Domestic Manufacturing#Raw-Material Management Center
Bill No. 2219780Committee Review

Partial Amendment to the Act on the Control of Narcotics

Rep. 신성범 et al. (10 lawmakers in total) · Proposed 2026-07-06 · Health and Welfare Committee

View Bill →
Received
Committee Review
Legal Review
Plenary Session
Sent to Gov.
Enacted

This bill would exclude hemp containing no more than 0.3% THC by dry weight from the statutory definition of cannabis, enabling lawful use across medical, functional-food, cosmetics, textile and feed sectors. It reflects WHO recommendations and the UN Commission on Narcotic Drugs decision on cannabis scheduling, while extending the industrialization model demonstrated in the Gyeongbuk Hemp Regulatory Free Zone nationwide.

Key Provisions

  • ✓Excludes hemp containing no more than 0.3% THC from the statutory definition of cannabis
  • ✓Allows lawful use in medical, functional-food, cosmetics, textile, feed and other sectors
  • ✓Reflects WHO recommendations and the UN Commission on Narcotic Drugs decision in domestic law
  • ✓Extends the Gyeongbuk Hemp Regulatory Free Zone model into a nationwide framework
#Hemp#THC 0.3%#Act on the Control of Narcotics#Cannabis Exclusion#Industrialization

This page is based on publicly available data from the Korean National Assembly Bill Information System. Legislative status may not reflect real-time updates. For the latest information, please visit the National Assembly Bill Information System.